As a Sir Henry Wellcome Fellow at the University of Cambridge, Dr. Kärt Tomberg works on mapping the combinatorial landscape of known immune checkpoints as well as discovering new targets for immune activation against cancer using in vivo screens.
Kärt received both her Bachelor’s and Master’s degrees from the University of Tartu in her native Estonia. In 2010, she joined Prof. David Ginsburg’s lab at the University of Michigan as a Fulbright Science and Technology Fellow to work on her PhD thesis. Her thesis work focused on identifying novel genes involved in thrombosis using in vivo mutagenesis screens which led to multiple first author publications.
After graduating in 2016, Kärt spent the next 8 months travelling through Central and South America while finishing up papers and writing grants. She also spent some time teaching in school back in Estonia before joining Prof. Allan Bradley’s lab for her postdoctoral work.